A recombinant BCG-based vaccine against the human respiratory syncytial virus induces a balanced cellular immune response against viral and mycobacterial antigens

Gaspar A. Pacheco, Nicolás M. S. Gálvez, Catalina A. Andrade, Yaneisi Vázquez, Linmar Rodríguez-Guilarte, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis
doi: https://doi.org/10.1101/2022.02.07.22270648

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted February 09, 2022.
Download PDF

Supplementary Material

Data/Code
Email
A recombinant BCG-based vaccine against the human respiratory syncytial virus induces a balanced cellular immune response against viral and mycobacterial antigens
Gaspar A. Pacheco, Nicolás M. S. Gálvez, Catalina A. Andrade, Yaneisi Vázquez, Linmar Rodríguez-Guilarte, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis
medRxiv 2022.02.07.22270648; doi: https://doi.org/10.1101/2022.02.07.22270648
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area